2016
DOI: 10.1093/infdis/jiw639
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of HPV vaccination on prevalence of vaccine genotypes in young sexually active women in France

Abstract: Our study demonstrates evidence of high effectiveness of HPV prophylactic vaccines at an individual level, supporting that wider implementation will help to reduce cervical cancer and precursors incidence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
1

Year Published

2017
2017
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 26 publications
0
10
0
1
Order By: Relevance
“…Enrollment of study participants was restricted to particular age groups (<5, <18, ≥65) in seven (3%) influenza studies, five (21%) pneumococcal studies, three (6%) rotavirus studies, (50%) two poliovirus studies, one (17%) pertussis study, and one (100%) HPV study. Among studies that failed to control for age (n=12, 3%), three (25%) used other methods to examine the potential effect of age, such as by using stepwise regression (371).…”
Section: Approaches To Estimation Of Vementioning
confidence: 99%
“…Enrollment of study participants was restricted to particular age groups (<5, <18, ≥65) in seven (3%) influenza studies, five (21%) pneumococcal studies, three (6%) rotavirus studies, (50%) two poliovirus studies, one (17%) pertussis study, and one (100%) HPV study. Among studies that failed to control for age (n=12, 3%), three (25%) used other methods to examine the potential effect of age, such as by using stepwise regression (371).…”
Section: Approaches To Estimation Of Vementioning
confidence: 99%
“…7 The World Health Organization (WHO) and US Food and Drug Administration (FDA) recommends HPV vaccines for boys and girls aged 9 through 26, as approximately 50% of all new HPV infections are among youth between the ages of 15 and 24. 7,8 HPV vaccines have been found to provide up to 100% protection against some HPV types that can cause cancer, 7,9,10 yet uptake of the vaccine in the US has been slow. While improving, recent estimates indicate half of US adolescents are not fully immunized against HPV; 11 vaccination rates amongst US university students have also been suboptimal, especially for males.…”
Section: Introductionmentioning
confidence: 99%
“…It is worth stressing that observation research in which the effect of general HPV vaccinations on the population has also been assessed in numerous countries, and confirmed the high efficiency in preventing HPV contamination, precancer conditions of the cervix, vagina, vulva and condyles in women, and pre-cancer conditions of the penis, anus and condyles in men [14,15,16,17,18,19]. In this context, it seems justified to include HPV vaccinations in obligatory vaccination schedules, or possibly to organize with the Ministry of Health or National Health Fund, a general HPV vaccination programme.…”
Section: Discussionmentioning
confidence: 75%